Michael Milken

Michael Milken was born in 1946 in Encino, California. He pursued an education in finance, earning a bachelor’s degree from the University of California, Berkeley, and an MBA from the Wharton School of the University of Pennsylvania. During his time in graduate school, he began researching the high-yield bond market, which was then considered a fringe area of finance involving companies with lower credit ratings. This academic foundation would eventually propel his professional trajectory.

In the 1970s, Milken joined the investment banking firm Drexel Burnham Lambert, where he pioneered the market for high-yield bonds, often referred to as junk bonds. His work enabled smaller, growth-oriented companies to raise capital through debt instruments, fundamentally altering the corporate finance landscape. This innovation played a critical role in the rise of hostile takeovers and leveraged buyouts during the 1980s, establishing Milken as one of the most powerful and controversial figures on Wall Street.

His career reached a dramatic peak in the late 1980s as his influence grew, but he soon faced intense scrutiny from federal regulators. In 1990, Milken pleaded guilty to securities fraud and other charges, agreeing to a significant settlement and a multi-year prison sentence. Despite the legal setbacks and the subsequent public fallout, his structural impact on the evolution of corporate finance and modern debt markets remains a subject of extensive analysis.

Since his release, Milken has redirected his energy toward philanthropy and medical research. Through the Milken Institute and various foundations, he has focused on funding research for prostate cancer and advocating for public policy changes. With a reported net worth of 6 billion dollars, he continues to operate as a prominent voice in business and health advocacy, maintaining a complex legacy that spans from the aggressive financial expansion of the 1980s to his current role as a significant philanthropic donor.